Rate this Article: Incidence and Risk Factors for Breakthrough Febrile Neutropenia in Cancer Patients Receiving Chemotherapy and Prophylactic Pegfilgrastim

Rating (1-10):

5

Comments (ART20171237): Full Name: Email Address:

Back to Article